Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1998 Jan;51(1):73–74. doi: 10.1136/jcp.51.1.73

Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary haemochromatosis.

D Baty 1, A Terron Kwiatkowski 1, D Mechan 1, A Harris 1, M J Pippard 1, D Goudie 1
PMCID: PMC500436  PMID: 9577377

Abstract

Genetic testing for hereditary haemochromatosis is likely to be a significant workload for diagnostic laboratories. The C282Y and H63D mutations in the HFE gene associated with hereditary haemochromatosis have previously been detected using a number of methods including alterations in the restriction digest pattern of polymerase chain reaction (PCR) amplified products. An amplification refractory mutation system (ARMS) has been developed that will simultaneously detect both hereditary haemochromatosis mutations. Comparison of the results obtained from the analysis of 46 samples referred for hereditary haemochromatosis testing showed no discrepancies between ARMS and restriction enzyme digestion. Furthermore, consistent results were obtained by ARMS from both blood and buccal mouthwash samples. The ARMS test is quicker and less expensive in terms of consumables and scientist time than restriction enzyme analysis, and is therefore suited to the routine diagnostic analysis of hereditary haemochromatosis.

Full text

PDF
73

Images in this article

74Image
on p.74

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutler E., Gelbart T., West C., Lee P., Adams M., Blackstone R., Pockros P., Kosty M., Venditti C. P., Phatak P. D. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis. 1996;22(2):187–194b. doi: 10.1006/bcmd.1996.0027. [DOI] [PubMed] [Google Scholar]
  2. Borot N., Roth M., Malfroy L., Demangel C., Vinel J. P., Pascal J. P., Coppin H. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics. 1997;45(5):320–324. doi: 10.1007/s002510050211. [DOI] [PubMed] [Google Scholar]
  3. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Jr, Ellis M. C., Fullan A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar]
  4. Ferrie R. M., Schwarz M. J., Robertson N. H., Vaudin S., Super M., Malone G., Little S. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet. 1992 Aug;51(2):251–262. [PMC free article] [PubMed] [Google Scholar]
  5. Jazwinska E. C., Cullen L. M., Busfield F., Pyper W. R., Webb S. I., Powell L. W., Morris C. P., Walsh T. P. Haemochromatosis and HLA-H. Nat Genet. 1996 Nov;14(3):249–251. doi: 10.1038/ng1196-249. [DOI] [PubMed] [Google Scholar]
  6. Jouanolle A. M., Gandon G., Jézéquel P., Blayau M., Campion M. L., Yaouanq J., Mosser J., Fergelot P., Chauvel B., Bouric P. Haemochromatosis and HLA-H. Nat Genet. 1996 Nov;14(3):251–252. doi: 10.1038/ng1196-251. [DOI] [PubMed] [Google Scholar]
  7. Kirschbaum N. E., Foster P. A. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance. Thromb Haemost. 1995 Sep;74(3):874–878. [PubMed] [Google Scholar]
  8. Merryweather-Clarke A. T., Pointon J. J., Shearman J. D., Robson K. J. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997 Apr;34(4):275–278. doi: 10.1136/jmg.34.4.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Newton C. R., Graham A., Heptinstall L. E., Powell S. J., Summers C., Kalsheker N., Smith J. C., Markham A. F. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989 Apr 11;17(7):2503–2516. doi: 10.1093/nar/17.7.2503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Niederau C., Fischer R., Pürschel A., Stremmel W., Häussinger D., Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996 Apr;110(4):1107–1119. doi: 10.1053/gast.1996.v110.pm8613000. [DOI] [PubMed] [Google Scholar]
  11. Roberts A. G., Whatley S. D., Morgan R. R., Worwood M., Elder G. H. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet. 1997 Feb 1;349(9048):321–323. doi: 10.1016/S0140-6736(96)09436-6. [DOI] [PubMed] [Google Scholar]
  12. Schwarz M. J., Malone G. M., Haworth A., Cheadle J. P., Meredith A. L., Gardner A., Sawyer I. H., Connarty M., Dennis N., Seller A. Cystic fibrosis mutation analysis: report from 22 U.K. regional genetics laboratories. Hum Mutat. 1995;6(4):326–333. doi: 10.1002/humu.1380060406. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES